These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15845652)

  • 1. The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore.
    Ceschi M; Sun CL; Van Den Berg D; Koh WP; Yu MC; Probst-Hensch N
    Carcinogenesis; 2005 Aug; 26(8):1457-64. PubMed ID: 15845652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study.
    Probst-Hensch NM; Sun CL; Van Den Berg D; Ceschi M; Koh WP; Yu MC
    Carcinogenesis; 2006 Dec; 27(12):2475-82. PubMed ID: 16829689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marine n-3 fatty acid intake, glutathione S-transferase polymorphisms and breast cancer risk in post-menopausal Chinese women in Singapore.
    Gago-Dominguez M; Castelao JE; Sun CL; Van Den Berg D; Koh WP; Lee HP; Yu MC
    Carcinogenesis; 2004 Nov; 25(11):2143-7. PubMed ID: 15256483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cyclin D1 genotype with breast cancer risk and survival.
    Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GG genotype of cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China.
    Jia A; Gong J; Li Y; Hao Z; Chang X; Dai F; Yu B
    Scand J Gastroenterol; 2008; 43(11):1353-9. PubMed ID: 18609126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk.
    Park SK; Yim DS; Yoon KS; Choi IM; Choi JY; Yoo KY; Noh DY; Choe KJ; Ahn SH; Hirvonen A; Kang D
    Breast Cancer Res Treat; 2004 Nov; 88(1):55-62. PubMed ID: 15538046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 polymorphism and the risk of endometrial cancer.
    Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
    Naidu R; Yip CH; Taib NA
    Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
    Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
    Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
    In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.
    Spurdle AB; Chang JH; Byrnes GB; Chen X; Dite GS; McCredie MR; Giles GG; Southey MC; Chenevix-Trench G; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):769-74. PubMed ID: 17416769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
    Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
    Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between cyclin D1 (CCND1) polymorphism and gastric cancer risk in Japanese population.
    Tahara T; Arisawa T; Shibata T; Yamashita H; Hirata I
    Hepatogastroenterology; 2009; 56(93):1232-5. PubMed ID: 19760977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
    Saxena A; Dhillon VS; Raish M; Asim M; Rehman S; Shukla NK; Deo SV; Ara A; Husain SA
    Breast Cancer Res Treat; 2009 Jun; 115(3):537-43. PubMed ID: 18574688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore.
    Hong Y; Eu KW; Seow-Choen F; Fook-Chong S; Cheah PY
    Eur J Cancer; 2005 May; 41(7):1037-44. PubMed ID: 15862753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions.
    Huang M; Spitz MR; Gu J; Lee JJ; Lin J; Lippman SM; Wu X
    Carcinogenesis; 2006 Oct; 27(10):2034-7. PubMed ID: 16638786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract.
    Buch S; Zhu B; Davis AG; Odom D; Siegfried JM; Grandis JR; Romkes M
    Mol Carcinog; 2005 Apr; 42(4):222-8. PubMed ID: 15754315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of glutathione S-transferase T1, M1 and P1 genotypes and breast cancer risk.
    Unlü A; Ates NA; Tamer L; Ates C
    Cell Biochem Funct; 2008; 26(5):643-7. PubMed ID: 18521819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCND1 and CDKN1B polymorphisms and risk of breast cancer.
    Canbay E; Eraltan IY; Cercel A; Isbir T; Gazioglu E; Aydogan F; Cacina C; Cengiz A; Ferahman M; Zengin E; Unal H
    Anticancer Res; 2010 Jul; 30(7):3093-8. PubMed ID: 20683061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.